Some OEMs choose to mold parts and products in-house to maintain control over processes, protect intellectual property, and integrate into the larger work stream. Many often struggle, however, to maintain the proper level of resource investment necessary given the capital-intense nature of the injection molding business.
Frequently, the original decision to mold in-house to save costs, streamline the supply chain, and protect intellectual property causes OEMs to be left scrambling when things go wrong. Whether the program gets derailed by poor quality tooling, the wrong downstream equipment, or a lack of ongoing investment and resources, it’s important to ask, “Is it time to outsource our molding business?”
Members of management at OEMs struggling with the answer to this que
Continue reading this story and get 24/7 access to Medical Product Outsourcing for FREE
Our in-depth coverage includes comprehensive feature articles, industry news, trends, and other developments pertinent to the service provider-OEM relationship. MPO examines the increasingly complex and demanding requirements of managing outsourcing partnerships. From regulatory mandates and manufacturing best practices to market shifts and legal concerns, our website is filled with exclusive content to help device manufacturers and their vendors stay informed. Join Today!
FREE SUBSCRIPTION